跳至主要内容
临床试验/NL-OMON43409
NL-OMON43409已完成不适用

Protocol for Cervical Cancer Screening FCM Feasibility Study in EU. Measurement of the cell proliferation status / detection of cervical lesions for rapid screening (high throughput) of Cervical Cancer with the LC-1000 - Protocol for Cervical Cancer Screening FCM Feasibility Study in EU.

Sysmex Europe GmbH0 个研究点目标入组 500 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • females older than 20 years who visit a gynaecologist for a cervical smear

排除标准

  • females younger than 20 years, pregnant women, women who were deemed inappropriate by their gynecologist to participate in this study, and women who underwent cervical conisation* (or total hysterectomy). However, after a certain period (approx. 6 month) following cervical conisation, it*s possible to participate in this study at the discretion of the gynecologist.

研究者

发起方
Sysmex Europe GmbH

相似试验

Protocol for Cervical Cancer Screening FCM... | 临床试验